Evidence map›Paper›PMID 36109766›Full record

Trial reportTrials2022

Development and evaluation of an electronic algorithm using a combination of a two-step malaria RDT and other rapid diagnostic tools for the management of febrile illness in children under 5 attending outpatient facilities in Burkina Faso.

Francois Kiemde, Adelaide Compaore, Fla Koueta, Athanase M Some, Berenger Kabore, Daniel Valia, Toussaint Rouamba, Fadima Yaya Bocoum, Seydou Sawadogo, Macaire Nana and 10 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05285657 (Development and Evaluation of an Electronic Algorithm Using a Combination of a Two-step Malaria RDT, and Other Rapid Diagnostic Tools for the Management of Febrile Illness in Children Under 5 Attending Outpatient Facilities in Burkina Faso.), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05285657 nacompletednot on this map

Development and Evaluation of an Electronic Algorithm Using a Combination of a Two-step Malaria RDT, and Other Rapid Diagnostic Tools for the Management of Febrile Illness in Children Under 5 Attending Outpatient Facilities in Burkina Faso.

TypeinterventionalSponsorInstitut de Recherche en Sciences de la Sante, Burkina FasoRan2022 to 2023Enrolled1,176ConditionsAntimicrobial ResistanceArmsTwo-step malaria RDT detecting PfHRP2/pLDH (SD Ag Bioline Malaria Ag P.f/Pan: Standard Diagnostics, Hagal-Dong, Korea)
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 2 countries.

Francois KiemdeInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso. kiemdefrancois@yahoo.fr.ORCID http://orcid.org/0000-0001-8828-5749
Adelaide CompaoreInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Fla KouetaDepartment of Pediatrics - CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso.
Athanase M SomeInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Berenger KaboreInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Daniel ValiaInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Toussaint RouambaInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Fadima Yaya BocoumInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Seydou SawadogoInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Macaire NanaHealth District of Nanoro, Ministry of Health, Nanoro, Burkina Faso.
Diane Y SomeInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Nadine A KoneInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Valentin PagbeleguemInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Inoussa SangareInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Antonia W BereInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Massa Dit Achille BonkoInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Gautier TougriNational Malaria Control Program, Ministry of Health, Ouagadougou, Burkina Faso.
Sylvie Yeri YoulNational Agency for Primary Healthcare, Ministry of Health, Ouagadougou, Burkina Faso.
Henk SchalligAmsterdam University Medical Centers, Academic Medical Centre at the University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory for Experimental Parasitology, Amsterdam Institute for Infection and Immunity, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands.
Halidou TintoInstitut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), Nanoro, Burkina Faso.
Institut de Recherche en Sciences de la Santé · BFAmsterdam University Medical Centers · NLCentre Hospitalier Universitaire Yalgado Ouédraogo · BF

Funding

European and Developing Countries Clinical Trials Partnership TMA2019CDF-2697
6 · The paper itself

Abstract

backgroundIn Sub-Saharan Africa (SSA), febrile illnesses remain a major public health problem in children. However, the persistence of hrp2 antigen and the low sensitivity of pLDH RDT negatively affect antimalarials and antibiotics prescription practices. These limitations lead to poor management of febrile diseases and antimicrobial resistance (AMR). To improve the diagnosis of these febrile diseases and subsequent prescription of antimicrobials, it is hypothesized that the implementation of an algorithm including a two-step malaria RDT PfHRP2/pLDH supported by point-of-care (PoC) tests for bacterial infections could significantly improve the management of febrile diseases and thereby tackling AMR.

methodsTo assess the value of the proposed algorithm, an open-label randomized controlled trial with three arms, enrolling febrile children from 6 to 59 months is proposed. In the control arm, febrile children will be managed according to the Integrated Management of Childhood Illnesses (IMCI), which is part of the standard of care in Burkina Faso. Treatment will be done according to national guidelines. In the RDT decisional algorithm (RDT-DA) arm (intervention), the clinical examination based on IMIC will be supported by a two-step malaria RDT and bacterial infections RDTs. Prescription will be left to the discretion of the healthcare workers based on clinical examination and PoC test results. In the e-algorithm arm (intervention), artificial intelligence integrating multiple layers of clinical information such as clinical examination, signs/symptoms and medical history, and biological information such as biomarkers (CRP and WBC) and pathogen-specific PoC tests, and oximetry will be developed. The e-algorithm will serve to guide the diagnostic and management of febrile infections in children. In the 3 arms, the case report forms will be digitalized. A final follow-up visit (day 7) will be scheduled for all participants. Patients will be asked to come back to the health facilities before the scheduled visit if the symptoms persist or in case of health condition worsening. DISCUSSION: If successful, this study could contribute to improve the management of febrile diseases and reduce inappropriate use of antimicrobials.

trial registrationThe trial is registered at ClinicalTrial.gov, NCT05285657. Enrolment started on 4 March 2022 with long-term outcome being assessed completely by 2023.

Indexed as

AntimalarialsMalariaMalaria, FalciparumAlgorithmsAnti-Bacterial AgentsArtificial IntelligenceBurkina FasoChild, PreschoolElectronicsFeverHumansInfantOutpatientsAnti-Bacterial AgentsAntimalarialsArtificial intelligencee-AlgorithmFeverPrescriptionRapid diagnostic test

Identifiers

PMID36109766
PMCPMC9476427
OpenAlexW4296031906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.